1620P Inherited variants in SRD5A genes and response to hormonal therapy in prostate cancer (SWOG S1216)
Ingles S, Pinski J, Manojlovic Z, Xiong S, Weisenberger D, Goldkorn A, Tangen C, McConkey D, Lara P, Hussain M, Quinn D, Thompson I, Lerner S, Dorff T, Agarwal N. 1620P Inherited variants in SRD5A genes and response to hormonal therapy in prostate cancer (SWOG S1216). Annals Of Oncology 2024, 35: s978. DOI: 10.1016/j.annonc.2024.08.1701.Peer-Reviewed Original ResearchDEVELOPMENT AND TESTING OF A CUSTOM NANOSTRING RNA CODESET FOR MUSCLE-INVASIVE BLADDER CANCER UTILIZING TCGA SUBTYPING (SWOG S1011)
Patel S, Anurag M, Lerner S, Lucia S, Meeks J, McConkey D, Kim J. DEVELOPMENT AND TESTING OF A CUSTOM NANOSTRING RNA CODESET FOR MUSCLE-INVASIVE BLADDER CANCER UTILIZING TCGA SUBTYPING (SWOG S1011). Urologic Oncology Seminars And Original Investigations 2024, 42: s31-s32. DOI: 10.1016/j.urolonc.2024.01.111.Peer-Reviewed Original ResearchMuscle-invasive bladder cancerSubtype callsLuminal papillaryRNA sequencingMIBC subtypesTumor subtypesMolecular subtypesSubtype classificationPatient classifierTCGA subtypesComprehensive genomic profilingResponse to chemotherapyFormalin-fixed paraffin-embedded (FFPEPatient biopsy tissueParaffin-embedded (FFPEWhole-transcriptome RNA sequencingTranscriptome RNA sequencingRNA-seqClinical outcomesBladder cancerBiopsy tissueHeterogeneous diseaseRNA-based classifiersRNA samplesSWOG